NCT05029648

Brief Summary

Evaluation of predictive factors for psoas tendinitis after first-line total hip arthroplasty. A single-centre retrospective study of medical data from the medical records of patients undergoing total hip arthroplasty.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,199

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 11, 2011

Completed
10 years until next milestone

First Submitted

Initial submission to the registry

August 16, 2021

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 31, 2021

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 19, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 19, 2024

Completed
Last Updated

July 3, 2024

Status Verified

July 1, 2024

Enrollment Period

12.9 years

First QC Date

August 16, 2021

Last Update Submit

July 1, 2024

Conditions

Psoas Tendinitis

Outcome Measures

Primary Outcomes (1)

  • Psoas tendinitis development

    Pain remission after tenotomy.

    6 months

Secondary Outcomes (2)

  • Psoas tendinitis occurrence frequency

    6 months

  • To describe the outcome of patients who have undergone tenotomy

    6 months

Study Arms (1)

Cohort

Simple cohort

Other: Cohort

Interventions

CohortOTHER

Cohort

Cohort

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who have had a total hip replacement for at least six months.

You may qualify if:

  • Patient aged 18 years or older, having been informed of the research
  • Patient who has had a total hip replacement implanted for at least six months as a first-line treatment
  • Patient who has been regularly monitored since the operation and for whom all clinical and radiological data are available during follow-up visits

You may not qualify if:

  • Patient undergoing revision surgery
  • Patient who has indicated his opposition to the use of his medical data
  • Patient under legal protection, guardianship or curators

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique de la Sauvegarde

Lyon, 69009, France

Location

MeSH Terms

Interventions

Cohort Studies

Intervention Hierarchy (Ancestors)

Epidemiologic StudiesEpidemiologic Study CharacteristicsEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Nicolas BONIN, MD

    Clinique de la Sauvegarde

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2021

First Posted

August 31, 2021

Study Start

August 11, 2011

Primary Completion

June 19, 2024

Study Completion

June 19, 2024

Last Updated

July 3, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations

FR(1)